An Emerging Pediatric CNS Tumor: Imaging Evaluation of H3K27M and BRAF V600E Comutated Midline Tumors
Authors:
- Vanessa RamehVRVanessa Rameh
- Loai AkerLALoai Aker
- Sridhar VajapeyamSVSridhar Vajapeyam
- Alireza ZiaeiAZAlireza Ziaei
- Kee Kiat YeoKYKee Kiat Yeo
- Cesar AlvesCACesar Alves
- Lissa C. BairdLBLissa C. Baird
- Katie P. FehnelKFKatie P. Fehnel
- Karen WrightKWKaren Wright
- Susan ChiSCSusan Chi
- Hart G. LidovHLHart G. Lidov
- Sanda AlexandrescuSASanda Alexandrescu
- 17 September 2025
- journal article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 809-815
Abstract
BACKGROUND AND PURPOSE: Diffuse midline gliomas (DMG) with concurrent H3K27M and BRAF V600E mutations represent a rare and poorly studied subset of pediatric central nervous system tumors. While traditionally associated with poor prognosis, recent evidence suggests that MAPK pathway alterations may confer improved outcomes in select cases. This study aims to explore the imaging characteristics of H3K27M/BRAF V600E coaltered midline gliomas. MATERIALS AND METHODS: Eight pediatric patients (6 males, 2 females; age range: 3–18 years, mean: 11 years) with H3K27M/BRAFV600E-mutant midline tumors were retrospectively reviewed. Data collected included MR imaging features, histopathologic and molecular data, treatment, and follow-up outcomes. RESULTS: Of the eight patients identified, six (n=6/8; 75%) were thalamic, with the remainder involving the hypothalamus/optic pathway and cervical spine. Tumors demonstrated heterogeneous histology: pediatric-type low-grade glioma-like (n=3), ganglioglioma-like (n=3), and high-grade glioma-like (n=2). All tumors were midline in location. Thalamic tumors were well-demarcated but demonstrated infiltrative and exophytic components, with frequent involvement of the third ventricle (n=4/6;66.7%) and internal capsule (n=4/6;66.7%). Imaging demonstrated heterogeneous T1/T2 signal with coarse calcifications in five of thalamic tumors. Hydrocephalus was present in all patients with thalamic lesions. These tumors demonstrated varied diffusion characteristics with areas of intermediate and reduced diffusivity. Enhancement was present but heterogeneous across tumor types. Both HGG-like tumors presented with cranial and spinal leptomeningeal metastases. CONCLUSIONS: DMGs harboring both H3K27M and BRAFV600E mutations may represent a distinct subtype, with radiologic, histopathologic, and molecular features that appear different from those of non-MAPK–altered H3K27M DMGs. ABBREVIATIONS: World Health Organization = WHO, Diffuse midline glioma = DMG, Mitogen-activated protein kinase = MAPK, Formalin-fixed paraffin-embedded = FFPE, Wild-type = WT, Overall survival = OS, Contrast-enhanced = CE, High-grade gliomas = HGGs, Long-term survival = LTS, Short-term survival= STSKeywords
This publication has 25 references indexed in Scilit:
- A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisationActa Neuropathologica, 2023
- H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implicationsJournal of Neuropathology & Experimental Neurology, 2023
- Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsActa Neuropathologica, 2023
- A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4Acta Neuropathologica, 2023
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutationsBrain Tumor Pathology, 2019
- H3 K27M–mutant diffuse midline gliomas in different anatomical locationsHuman Pathology, 2018
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesActa Neuropathologica, 2015
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of GlioblastomaCancer Cell, 2012
- FSLNeuroImage, 2012